Global and Region Autoimmune Disorders Treatment Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Autoimmune Disorders Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Autoimmune Disorders Treatmentmarket, defines the market attractiveness level of Autoimmune Disorders Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Autoimmune Disorders Treatment industry, describes the types of Autoimmune Disorders Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Autoimmune Disorders Treatment market and the development prospects and opportunities of Autoimmune Disorders Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Autoimmune Disorders Treatment market in Chapter 13.

    By Player:

    • Genentech, Inc

    • F Hoffmann-La Roche Ltd

    • Beckman Coulter, Inc

    • AstraZeneca

    • Autoimmune Inc

    • Biogen

    • Bayer AG

    • Abbott

    • Johnson & Johnson Services, Inc

    • Eli Lilly and Company

    • Amgen Inc

    • GlaxoSmithKline plc

    • Chugai Pharmaceutical Co, Ltd

    • LUPIN

    • Siemens Healthcare

    • Bristol-Myers Squibb Company

    • Thermo Fisher Scientific Inc

    • Pfizer Inc

    • Merck Sharp & Dohme Corp

    By Type:

    • Diagnostic Equipment

    • Drugs

    • Therapeutic & Monitoring Equipment

    By End-User:

    • Hospital

    • Medical Center

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Autoimmune Disorders Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Autoimmune Disorders Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Autoimmune Disorders Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Autoimmune Disorders Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Autoimmune Disorders Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Autoimmune Disorders Treatment Consumption (2017-2022)

    • 7.2 United States Autoimmune Disorders Treatment Consumption (2017-2022)

    • 7.3 Europe Autoimmune Disorders Treatment Consumption (2017-2022)

    • 7.4 China Autoimmune Disorders Treatment Consumption (2017-2022)

    • 7.5 Japan Autoimmune Disorders Treatment Consumption (2017-2022)

    • 7.6 India Autoimmune Disorders Treatment Consumption (2017-2022)

    • 7.7 South Korea Autoimmune Disorders Treatment Consumption (2017-2022)

    8 Region and Country-wise Autoimmune Disorders Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Autoimmune Disorders Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Autoimmune Disorders Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Autoimmune Disorders Treatment Consumption Forecast (2022-2028)

    • 8.4 China Autoimmune Disorders Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Autoimmune Disorders Treatment Consumption Forecast (2022-2028)

    • 8.6 India Autoimmune Disorders Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Autoimmune Disorders Treatment Consumption Forecast (2022-2028)

    9 Global Autoimmune Disorders Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Autoimmune Disorders Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diagnostic Equipment Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Therapeutic & Monitoring Equipment Consumption and Growth Rate (2017-2022)

    • 9.2 Global Autoimmune Disorders Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medical Center Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Autoimmune Disorders Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Autoimmune Disorders Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diagnostic Equipment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Therapeutic & Monitoring Equipment Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Autoimmune Disorders Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Medical Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Autoimmune Disorders Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Autoimmune Disorders Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Autoimmune Disorders Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Autoimmune Disorders Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Autoimmune Disorders Treatment Market Competitive Analysis

    • 14.1 Genentech, Inc

      • 14.1.1 Genentech, Inc Company Details

      • 14.1.2 Genentech, Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Genentech, Inc Autoimmune Disorders Treatment Product and Service

    • 14.2 F Hoffmann-La Roche Ltd

      • 14.2.1 F Hoffmann-La Roche Ltd Company Details

      • 14.2.2 F Hoffmann-La Roche Ltd Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 F Hoffmann-La Roche Ltd Autoimmune Disorders Treatment Product and Service

    • 14.3 Beckman Coulter, Inc

      • 14.3.1 Beckman Coulter, Inc Company Details

      • 14.3.2 Beckman Coulter, Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Beckman Coulter, Inc Autoimmune Disorders Treatment Product and Service

    • 14.4 AstraZeneca

      • 14.4.1 AstraZeneca Company Details

      • 14.4.2 AstraZeneca Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AstraZeneca Autoimmune Disorders Treatment Product and Service

    • 14.5 Autoimmune Inc

      • 14.5.1 Autoimmune Inc Company Details

      • 14.5.2 Autoimmune Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Autoimmune Inc Autoimmune Disorders Treatment Product and Service

    • 14.6 Biogen

      • 14.6.1 Biogen Company Details

      • 14.6.2 Biogen Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Biogen Autoimmune Disorders Treatment Product and Service

    • 14.7 Bayer AG

      • 14.7.1 Bayer AG Company Details

      • 14.7.2 Bayer AG Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer AG Autoimmune Disorders Treatment Product and Service

    • 14.8 Abbott

      • 14.8.1 Abbott Company Details

      • 14.8.2 Abbott Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Abbott Autoimmune Disorders Treatment Product and Service

    • 14.9 Johnson & Johnson Services, Inc

      • 14.9.1 Johnson & Johnson Services, Inc Company Details

      • 14.9.2 Johnson & Johnson Services, Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Johnson & Johnson Services, Inc Autoimmune Disorders Treatment Product and Service

    • 14.10 Eli Lilly and Company

      • 14.10.1 Eli Lilly and Company Company Details

      • 14.10.2 Eli Lilly and Company Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Eli Lilly and Company Autoimmune Disorders Treatment Product and Service

    • 14.11 Amgen Inc

      • 14.11.1 Amgen Inc Company Details

      • 14.11.2 Amgen Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Amgen Inc Autoimmune Disorders Treatment Product and Service

    • 14.12 GlaxoSmithKline plc

      • 14.12.1 GlaxoSmithKline plc Company Details

      • 14.12.2 GlaxoSmithKline plc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 GlaxoSmithKline plc Autoimmune Disorders Treatment Product and Service

    • 14.13 Chugai Pharmaceutical Co, Ltd

      • 14.13.1 Chugai Pharmaceutical Co, Ltd Company Details

      • 14.13.2 Chugai Pharmaceutical Co, Ltd Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Chugai Pharmaceutical Co, Ltd Autoimmune Disorders Treatment Product and Service

    • 14.14 LUPIN

      • 14.14.1 LUPIN Company Details

      • 14.14.2 LUPIN Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 LUPIN Autoimmune Disorders Treatment Product and Service

    • 14.15 Siemens Healthcare

      • 14.15.1 Siemens Healthcare Company Details

      • 14.15.2 Siemens Healthcare Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Siemens Healthcare Autoimmune Disorders Treatment Product and Service

    • 14.16 Bristol-Myers Squibb Company

      • 14.16.1 Bristol-Myers Squibb Company Company Details

      • 14.16.2 Bristol-Myers Squibb Company Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Bristol-Myers Squibb Company Autoimmune Disorders Treatment Product and Service

    • 14.17 Thermo Fisher Scientific Inc

      • 14.17.1 Thermo Fisher Scientific Inc Company Details

      • 14.17.2 Thermo Fisher Scientific Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Thermo Fisher Scientific Inc Autoimmune Disorders Treatment Product and Service

    • 14.18 Pfizer Inc

      • 14.18.1 Pfizer Inc Company Details

      • 14.18.2 Pfizer Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Pfizer Inc Autoimmune Disorders Treatment Product and Service

    • 14.19 Merck Sharp & Dohme Corp

      • 14.19.1 Merck Sharp & Dohme Corp Company Details

      • 14.19.2 Merck Sharp & Dohme Corp Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Merck Sharp & Dohme Corp Autoimmune Disorders Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Autoimmune Disorders Treatment

    • Figure Autoimmune Disorders Treatment Picture

    • Table Global Autoimmune Disorders Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Autoimmune Disorders Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Autoimmune Disorders Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Autoimmune Disorders Treatment Consumption by Country (2017-2022)

    • Figure United States Autoimmune Disorders Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Autoimmune Disorders Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Autoimmune Disorders Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Autoimmune Disorders Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Autoimmune Disorders Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Autoimmune Disorders Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disorders Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Autoimmune Disorders Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Autoimmune Disorders Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Autoimmune Disorders Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Autoimmune Disorders Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Autoimmune Disorders Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Autoimmune Disorders Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Equipment Consumption and Growth Rate (2017-2022)

    • Figure Global Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic & Monitoring Equipment Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Center Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Equipment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic & Monitoring Equipment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Autoimmune Disorders Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Autoimmune Disorders Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Genentech, Inc (Foundation Year, Company Profile and etc.)

    • Table Genentech, Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech, Inc Autoimmune Disorders Treatment Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Autoimmune Disorders Treatment Product and Service

    • Table Beckman Coulter, Inc (Foundation Year, Company Profile and etc.)

    • Table Beckman Coulter, Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckman Coulter, Inc Autoimmune Disorders Treatment Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Autoimmune Disorders Treatment Product and Service

    • Table Autoimmune Inc (Foundation Year, Company Profile and etc.)

    • Table Autoimmune Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Autoimmune Inc Autoimmune Disorders Treatment Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Autoimmune Disorders Treatment Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Autoimmune Disorders Treatment Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Autoimmune Disorders Treatment Product and Service

    • Table Johnson & Johnson Services, Inc (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Services, Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Services, Inc Autoimmune Disorders Treatment Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Autoimmune Disorders Treatment Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Autoimmune Disorders Treatment Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Autoimmune Disorders Treatment Product and Service

    • Table Chugai Pharmaceutical Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Chugai Pharmaceutical Co, Ltd Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chugai Pharmaceutical Co, Ltd Autoimmune Disorders Treatment Product and Service

    • Table LUPIN (Foundation Year, Company Profile and etc.)

    • Table LUPIN Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table LUPIN Autoimmune Disorders Treatment Product and Service

    • Table Siemens Healthcare (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Autoimmune Disorders Treatment Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Autoimmune Disorders Treatment Product and Service

    • Table Thermo Fisher Scientific Inc (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Inc Autoimmune Disorders Treatment Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Autoimmune Disorders Treatment Product and Service

    • Table Merck Sharp & Dohme Corp (Foundation Year, Company Profile and etc.)

    • Table Merck Sharp & Dohme Corp Autoimmune Disorders Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme Corp Autoimmune Disorders Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.